COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Merida Biosciences develops Fc-engineered therapeutics that selectively bind and neutralize pathogenic antibodies and target autoreactive B cells, pursuing programs in Graves’ disease, allergy, and primary membranous nephropathy.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
